Oppenheimer & Co. Inc. decreased its position in UnitedHealth Group Incorporated (NYSE:UNH) by 17.9% during the 2nd quarter, according to its most recent disclosure with the SEC. The fund owned 21,895 shares of the healthcare conglomerate’s stock after selling 4,770 shares during the period. Oppenheimer & Co. Inc.’s holdings in UnitedHealth Group were worth $4,060,000 at the end of the most recent reporting period.

A number of other institutional investors have also recently bought and sold shares of the business. Blue Chip Partners Inc. acquired a new stake in shares of UnitedHealth Group during the second quarter valued at $110,000. Patriot Financial Group Insurance Agency LLC boosted its stake in shares of UnitedHealth Group by 1,722.9% during the first quarter. Patriot Financial Group Insurance Agency LLC now owns 638 shares of the healthcare conglomerate’s stock valued at $106,000 after acquiring an additional 603 shares during the last quarter. Mitsubishi UFJ Securities Holdings Co. Ltd. boosted its stake in shares of UnitedHealth Group by 433.3% during the second quarter. Mitsubishi UFJ Securities Holdings Co. Ltd. now owns 640 shares of the healthcare conglomerate’s stock valued at $119,000 after acquiring an additional 520 shares during the last quarter. BDO Wealth Advisors LLC acquired a new stake in shares of UnitedHealth Group during the second quarter valued at $121,000. Finally, Kings Point Capital Management boosted its stake in shares of UnitedHealth Group by 27.9% during the first quarter. Kings Point Capital Management now owns 687 shares of the healthcare conglomerate’s stock valued at $113,000 after acquiring an additional 150 shares during the last quarter. 86.14% of the stock is currently owned by institutional investors.

Several equities analysts recently weighed in on the company. Zacks Investment Research downgraded UnitedHealth Group from a “buy” rating to a “hold” rating in a research report on Thursday. Credit Suisse Group assumed coverage on UnitedHealth Group in a research report on Thursday. They set an “outperform” rating and a $233.00 target price on the stock. Mizuho reiterated a “buy” rating on shares of UnitedHealth Group in a research report on Tuesday, October 24th. Oppenheimer Holdings, Inc. increased their target price on UnitedHealth Group from $215.00 to $205.00 and gave the stock an “outperform” rating in a research report on Wednesday, October 18th. Finally, Sanford C. Bernstein reiterated an “outperform” rating and set a $219.00 target price (up from $210.00) on shares of UnitedHealth Group in a research report on Thursday, October 19th. Three equities research analysts have rated the stock with a hold rating and twenty-four have given a buy rating to the company’s stock. UnitedHealth Group has a consensus rating of “Buy” and an average target price of $216.65.

Shares of UnitedHealth Group Incorporated (UNH) opened at $212.87 on Monday. The company has a market capitalization of $205,815.48, a PE ratio of 22.17, a P/E/G ratio of 1.58 and a beta of 0.64. The company has a current ratio of 0.70, a quick ratio of 0.72 and a debt-to-equity ratio of 0.52. UnitedHealth Group Incorporated has a twelve month low of $136.22 and a twelve month high of $213.83.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings data on Tuesday, October 17th. The healthcare conglomerate reported $2.66 earnings per share for the quarter, beating analysts’ consensus estimates of $2.57 by $0.09. UnitedHealth Group had a return on equity of 21.52% and a net margin of 4.50%. The firm had revenue of $50.32 billion during the quarter, compared to analyst estimates of $50.38 billion. During the same quarter last year, the firm earned $2.17 EPS. UnitedHealth Group’s quarterly revenue was up 8.7% on a year-over-year basis. research analysts predict that UnitedHealth Group Incorporated will post 9.99 earnings per share for the current year.

In other UnitedHealth Group news, insider Larry C. Renfro sold 50,574 shares of the firm’s stock in a transaction that occurred on Friday, September 15th. The stock was sold at an average price of $198.11, for a total transaction of $10,019,215.14. Following the completion of the sale, the insider now owns 195,625 shares in the company, valued at approximately $38,755,268.75. The sale was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, insider Thomas E. Roos sold 975 shares of the firm’s stock in a transaction that occurred on Thursday, October 19th. The shares were sold at an average price of $205.47, for a total value of $200,333.25. Following the sale, the insider now owns 24,630 shares of the company’s stock, valued at approximately $5,060,726.10. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 72,149 shares of company stock valued at $14,212,342. 0.89% of the stock is owned by insiders.

WARNING: This piece of content was reported by Watch List News and is the property of of Watch List News. If you are accessing this piece of content on another domain, it was copied illegally and reposted in violation of US and international copyright and trademark legislation. The original version of this piece of content can be viewed at https://www.watchlistnews.com/oppenheimer-co-inc-lowers-holdings-in-unitedhealth-group-incorporated-unh/1681974.html.

UnitedHealth Group Profile

UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH).

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Incorporated Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group Incorporated and related companies with Analyst Ratings Network's FREE daily email newsletter.